Isao Asari
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Low Serum IL-18 Levels May Predict the Effectiveness of Dupilumab in Severe Asthma.
Journal: Internal medicine (Tokyo, Japan)
Published: May 24, 2023
Leptin-producing monocytes in the airway submucosa may contribute to asthma pathogenesis.
Journal: Respiratory investigation
Published: March 17, 2022
Evaluation of cytokine levels in response to mitogen among HIV-1-infected blood cells and their relationships to the number of T cells.
Journal: Cytokine
Published: August 06, 2021
High serum cytokine levels may predict the responsiveness of patients with severe asthma to benralizumab.
Journal: The Journal of asthma : official journal of the Association for the Care of Asthma
Published: June 14, 2021
IL-1RA in the supernatant of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus is useful for discriminating active tuberculosis from latent infection.
Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
Published: August 20, 2020
A Low Serum CCL4/MIP-1β Level May Predict a Severe Asthmatic Responsiveness to Mepolizumab.
Journal: Internal medicine (Tokyo, Japan)
Published: July 28, 2020
Secretory IgA accumulated in the airspaces of idiopathic pulmonary fibrosis and promoted VEGF, TGF-β and IL-8 production by A549 cells.
Journal: Clinical and experimental immunology
Published: October 21, 2019
Evaluation of cytokine levels using QuantiFERON-TB Gold Plus in patients with active tuberculosis.
Journal: The Journal of infection
Published: April 04, 2019
Expression of Siglec-8 is regulated by interleukin-5, and serum levels of soluble Siglec-8 may predict responsiveness of severe eosinophilic asthma to mepolizumab.
Journal: Allergology international : official journal of the Japanese Society of Allergology
Published: December 18, 2017
Baseline serum CXCL10 and IL-12 levels may predict severe asthmatics' responsiveness to omalizumab.
Journal: Respiratory medicine
Published: August 02, 2017
Showing 1-10 of 10
Last Updated: 09/26/2026